PALIPALISADE BIO, INC.同业对比
PALISADE BIO, INC. 与SIC 2836 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PALI本股 | $278M#8 | 2.5x#1 | 2.3x#9 | — | — | -16.2%#8 | — | -13.8%#4 | — | — | 167.6%#1 | — |
| GRML | $454M#1 | — | 7.8x#12 | — | — | -71.6%#10 | — | -18.2%#5 | -14.6%#3 | — | -89.8%#7 | — |
| LXEO | $343M#2 | — | 1.5x#3 | 525.0x#7 | — | -1.7%#6 | -16706.0%#7 | -42.5%#10 | — | — | -23.4%#6 | — |
| CMPX | $341M#3 | — | 2.1x#7 | — | -100.0%#7 | -34.7%#9 | — | -40.0%#8 | — | — | — | — |
| IPSC | $333M#4 | — | 1.4x#2 | 3.1x#2 | 1556.8%#1 | 92.4%#2 | -15.8%#2 | -4.1%#2 | -9.3%#1 | — | — | — |
| IKT | $320M#5 | — | 2.1x#8 | — | -100.0%#7 | -75.4%#11 | — | -31.5%#7 | — | — | 49.7%#4 | — |
| SABS | $318M#6 | 14.6x#3 | 1.5x#4 | — | -100.0%#7 | 138.9%#1 | — | 6.2%#1 | — | — | 24.3%#5 | — |
| FATE | $303M#7 | — | 2.0x#5 | 45.6x#6 | -51.2%#6 | 26.8%#4 | -2222.4%#6 | -88.8%#11 | -102.3%#4 | — | 154.3%#2 | — |
| LCTX | $259M#9 | — | 4.3x#11 | 17.8x#5 | 53.2%#4 | -241.4%#13 | -251.6%#5 | -104.3%#12 | — | — | — | — |
| STRO | $253M#10 | — | — | 2.5x#1 | 65.2%#3 | 15.9%#5 | -154.5%#4 | — | — | — | 68.6%#3 | — |
| LIMN | $243M#11 | — | 808.8x#13 | — | — | -187.8%#12 | — | -3395.2%#13 | -170.3%#5 | — | — | — |
| IVVD | $224M#12 | — | 1.2x#1 | 4.2x#4 | 110.5%#2 | 69.1%#3 | -104.0%#3 | -29.0%#6 | — | — | — | — |
| PLX | $218M#14 | 11.8x#2 | 3.1x#10 | 4.1x#3 | -1.2%#5 | -325.2%#14 | -10.4%#1 | -9.2%#3 | -12.3%#2 | 3#1 | — | — |
| AVXL | $222M#13 | — | 2.0x#6 | — | — | -7.8%#7 | — | -41.2%#9 | — | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-20。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议